Microtubules are highly dynamic polymers composed of ␣␤-tubulin dimmers. As an important part of the cytoskeletal framework, microtubules have essential roles in cellular processes, including organelles positioning and transport [1, 2] , vesicle trafficking [3] and mitosis [4] . Microtubule-associated proteins (MAPs) and MAPs kinase are essential for the formation of cytoskeletal architecture [5, 6] . Temporal and spatial control of microtubule dynamics is crucial in mitotic spindle assembly, the mitotic checkpoint and chromosome movement [7, 8] 
. The most potent chemotherapeutic mechanism of paclitaxel is kinetic stabilization of spindle microtubule dynamics, which results in mitotic G2/M arrest and apoptosis [15] . In contrast, Vinca alkaloids such as vinblastine and vincristine introduce a wedge between two tubulin molecules thereby interfering with microtubule assembly [16] . Just [17] [18] [19] . Selective mutations within ␤-tubulin may interfere with the binding of taxol to its target or alter the microtubule stability. In addition, the spindle assembly checkpoint proteins and dysfunctional regulation of apoptotic signalling pathways contribute to variation in sensitivity to microtubules-targeted drugs [20] . Paclitaxel sensitivity is dependent on a functional spindle assembly checkpoint [21] . The tumour suppressor BRCA1 is linked to mitotic checkpoint through up-regulation of BubR1. BRCA1 down-regulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance [22] . Moreover, aurora-A overexpression can override the checkpoint mechanism that monitors mitotic spindle assembly and induce resistance to paclitaxel [23] . [24] . Although [26] [27] [28] . GRP78 is required for ER integrity and ER stress-induced autophagy [29] . Previous studies demonstrate that GRP78 confers resistance to chemotherapeutic drugs such as adriamycin, etoposide, 5-FU and temozolomide [27, 28, 30, 31] . More recently, it has been found that GRP78 confers chemoresistance to tumour-associated endothelial cells [32] . Here, we provide evidence that micro- (Fig. 2B) (Fig. 2C) . (Fig. 3) . Also, treatment with caspase-7 inhibitor partially compromised taxol-and vinblastine-induced cell death (Fig. 3) . These data imply that the activation of pro-apoptotic arms of the UPR may contribute to taxol-and vinblastine-induced cell death. (Fig. 4B) . Similar effects were observed in cells treated with EGCG and vinblastine (Fig. 4B) . These results demonstrated that EGCG could potentiate the pro-apoptotic signals induced by microtubules-interfering agents. (Fig. 5) (Fig. 6) . (Fig. 7) (Fig. 8) [2, 34] . Both ER and microtubules retract in taxol-treated cells [2] . Moreover, it has been revealed that ER extension occurs through a process whereby an ER tubule attaches to and elongates together with a growing microtubule. [36, 37] . Therefore, it appears that activation of the UPR can either synergize with or attenuate [27, 42] , temozolomide [30] , adriamycin-cisplatin [31] and quercetin [43] . Therefore, depletion of GRP78 may be an important adjunct in cancer therapy. Because GRP78 is also expressed at cancer cells surface, it may serve as a target for delivery of chemotherapeutic agents to tumours. A cyclic peptide-taxol conjugate has been shown to target GRP78-expressing cancer cells and selectively kill cancer cells [44] . In addition to regulate cell survival under ER stress, GRP78 have critical roles in tumour proliferation and angiogenesis [45] . Moreover, it has been demonstrated that GRP78 is involved in Akt phosphorylation [46] . Thus, the developments of small molecule inhibitors that specifically suppress GRP78 induction or its activity are justified. Recently, EGCG, a major component of green tea, has been identified as a natural GRP78 inhibitor [33] . Treatment with EGCG sensitizes malignant glioma cells to temozolomide [30] . 
like other classes of small tubulin-binding molecules, tubulin-targeted Vinca alkaloids have achieved chemotherapeutic success in selective subsets of patients with cancer. Disruption of microtubule dynamics is responsible for the ability of taxol and vinblastine to inhibit mitotic progression and induce apoptosis. Resistance to microtubule-targeted therapy is frequently encountered in the clinic. Previous studies have demonstrated that a variety of mechanisms may mediate intrinsic or acquired resistance to taxol-based chemotherapy, including ␤-tubulin isotypes, PI3K/Akt activation, stathmin and tau overexpression

The unfolded protein response (UPR) consists of multifaceted signal transduction cascades that are triggered by perturbations in the endoplasmic reticulum (ER) homeostasis. The UPR is not only critical for the development and normal function of secretory cell types, but also important for numerous human diseases such as neurodegenerative diseases, virus infection, diabetes and cancer
1B and C). The up-regulation of GRP78 could be detected after treatment of MCF-7 cells with 0.5 M taxol and 0.1 M vinblastine for 8 hrs (Fig. 1D). Next, we investigated the effects of taxol and vinblastine on other ER stress responsive proteins including spliced XBP-1 and phosphorylated eIF2␣. Treatment of MCF-7 cells with taxol or vinblastine for 6 hrs promoted XBP-1 splicing (Fig. 2A). During the UPR, a transient translation arrest is induced upon phosphorylation of eIF2␣ by PERK. The phosphorylation of eIF2␣ was observed after treatment of breast cancer cells with taxol or vinblastine for 4 hrs
To determine whether the activation of JNK and caspase-7 contributes to taxol-and vinblastine-induced cell death, the effect of JNK inhibitor and caspase-7 inhibitor on taxol-and vinblastineinduced cytotoxity was determined by WST1 assays. MCF-7 cells were treated with or without 5 M taxol, 1 M vinblastine, 10 M SP600125 or 50 M Ac-DEVD-CHO. Ac-DEVD-CHO is a caspase-3/7 inhibitor. Because caspase-3 is absent in MCF-7 cells, Ac-DEVD-CHO acts as caspase-7 inhibitor in MCF-7 cells. Treatment of MCF-7 cells with JNK inhibitor partially blocked taxol-and vinblastine-induced cell death
Suppression of GRP78 potentiates the activation of JNK and caspase-7 by taxol and vinblastine
Abrogation of GRP78 induction sensitizes breast cancer cells to taxol and vinblastine
. The results demonstrated that abrogation of GRP78 induction led to a significant decrease in colony survival for taxol-or vinblastinetreated cells (Fig. 5). These data indicate that suppression of GRP78 expression may lead to increased sensitivity of breast cancer cells to taxol and vinblastine. The above-mentioned results imply that down-regulation of GRP78 by compounds directed against GRP78 expression or activity could lead to increased sensitivity of breast cancer cells to microtubules-targeted agents. To determine whether the combination of EGCG and taxol or vinblastine can synergistically promote breast cancer cells death, the effect of EGCG, taxol or vinblastine alone and combination on cell survival was examined by colony formation assay. The results demonstrated that treatment of cells with EGCG in combination with taxol or vinblastine led to a dramatic decrease in cell survival compared to treatment with taxol or vinblastine alone
To determine whether apoptosis is responsible for the decreased viability in cells that are treated with EGCG and microtubules-targeted agents, the effect of EGCG, taxol or vinblastine alone and combination on cell apoptosis was examined by Hoechst 33342 staining. The results demonstrated that combination of EGCG and taxol or vinblastine led to significant increase in apoptosis compared to treatment with taxol or vinblastine alone
Inhibition of JNK and caspase-7 abrogates the sensitization of breast cancer cells to microtubules-targeted agents by EGCG
To determine whether the potentiation of JNK phosphorylation and caspase-7 cleavage by EGCG is responsible for EGCG sensitization of breast cancer cells to taxol and vinblastine, the effect of JNK inhibitor and caspase-7 inhibitor on EGCG-, taxol-and vinblastineinduced cytotoxity was determined by WST1 assays. MCF-7 cells
. Treatment with JNK inhibitor partially blocked taxol-and vinblastine-induced cell death, whereas caspase-7 inhibitor had little effect on taxoland vinblastine-induced cell death (Fig. 8). These data suggest that JNK, but not caspase-7, contributes to cell death induced by relatively low dose of taxol and vinblastine. Treatment with EGCG sensitized breast cancer cells to both taxol and vinblastine. Strikingly, both JNK inhibitor and caspase-7 inhibitor blocked EGCG sensitization of MCF-7 cells to taxol-and vinblastineinduced cytotoxity (Fig. 8). These data suggest that the potentiation of taxol-and vinblastine-induced JNK and caspase-7 activation by EGCG is involved in its sensitization of cancer cells to taxol and vinblastine.
An important question arises as to how taxol and vinblastine induce ER stress response. Both taxol and vinblastine can interfere with microtubules dynamics in different ways. The mechanism of ER stress response to microtubules-targeted agents is not clear and is likely to be complex. A connection of microtubules to ER remodelling is just emerging. ER tubules were often aligned with microtubules
Polymerization of individual microtubules and extension of individual
